BLOG

Oklahoma Pharmacy Board Unanimously Approves New Rules for Shipping Mail-Order Medications

Apr 5, 2023

New Oklahoma Rules for Shipping Mail-Order Medications Written-by: Deneen Fumich, RPh Pharma Solutions reported on January 4, 2023, Oklahoma was requesting comments from business entities affected by the proposed rule change focusing on prescription shipping...

Federal Regulation

DEA Reportedly Set to Revise SORS Guidelines and (Hopefully) Clarify the Meaning of “Suspicious”

Jan 18, 2018

DEA Reportedly Set to Revise SORS Guidelines and (Hopefully) Clarify the Meaning of “Suspicious” As the opioid crisis continues to grow and further...

Biggest Industry Players Face Pressure from Public and the DEA on Suspicious Order Monitoring

Jan 9, 2018

Biggest Industry Players Face Pressure from Public and the DEA on Suspicious Order Monitoring The Opioid Epidemic has been a devastating trend in...

Alabama’s New Rule Has Massive DSCSA Implications on State Regulations

May 24, 2023May 25, 2023

FDA – OA REMS Announcement Concerning requirements to Manufacturers of Opioids

May 2, 2023

BLOG

Oklahoma Pharmacy Board Unanimously Approves New Rules for Shipping Mail-Order Medications

DEA Reportedly Set to Revise SORS Guidelines and (Hopefully) Clarify the Meaning of “Suspicious”

Biggest Industry Players Face Pressure from Public and the DEA on Suspicious Order Monitoring

Alabama’s New Rule Has Massive DSCSA Implications on State Regulations

FDA – OA REMS Announcement Concerning requirements to Manufacturers of Opioids

Oklahoma Pharmacy Board Unanimously Approves New Rules for Shipping Mail-Order Medications

Alabama’s New Rule Has Massive DSCSA Implications on State Regulations

FDA – OA REMS Announcement Concerning requirements to Manufacturers of Opioids

Oklahoma Pharmacy Board Unanimously Approves New Rules for Shipping Mail-Order Medications

QUICK LINKS

CONTACT US

BLOG

Email Newsletter